532 related articles for article (PubMed ID: 27262488)
1. Targeted Mesoporous Silica Nanocarriers in Oncology.
Baeza A; Vallet-Regi M
Curr Drug Targets; 2018 Feb; 19(3):213-224. PubMed ID: 27262488
[TBL] [Abstract][Full Text] [Related]
2. Advances in Functionalized Mesoporous Silica Nanoparticles for Tumor Targeted Drug Delivery and Theranostics.
Zhang W; Liu M; Liu A; Zhai G
Curr Pharm Des; 2017; 23(23):3367-3382. PubMed ID: 27784244
[TBL] [Abstract][Full Text] [Related]
3. Smart Mesoporous Silica Nanocarriers for Antitumoral Therapy.
Baeza A; Vallet-Regí M
Curr Top Med Chem; 2015; 15(22):2306-15. PubMed ID: 26043739
[TBL] [Abstract][Full Text] [Related]
4. Advances in the Use of Multifunctional Mesoporous Silica Nanoparticles and Related Nanomaterials as Carriers for the Cancer Treatment.
Song C; Wang X; Wang Y; Yu H; Cui Y; Ma T
Curr Drug Metab; 2018; 19(2):131-141. PubMed ID: 28758578
[TBL] [Abstract][Full Text] [Related]
5. Tailored Mesoporous Silica Nanoparticles for Controlled Drug Delivery: Platform Fabrication, Targeted Delivery, and Computational Design and Analysis.
She X; Chen L; Yi Z; Li C; He C; Feng C; Wang T; Shigdar S; Duan W; Kong L
Mini Rev Med Chem; 2018; 18(11):976-989. PubMed ID: 27145854
[TBL] [Abstract][Full Text] [Related]
6. Mesoporous silica nanoparticles in nanomedicine applications.
Manzano M; Vallet-Regí M
J Mater Sci Mater Med; 2018 May; 29(5):65. PubMed ID: 29737405
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in porous nanoparticles for drug delivery in antitumoral applications: inorganic nanoparticles and nanoscale metal-organic frameworks.
Baeza A; Ruiz-Molina D; Vallet-Regí M
Expert Opin Drug Deliv; 2017 Jun; 14(6):783-796. PubMed ID: 27575454
[TBL] [Abstract][Full Text] [Related]
8. A Review on Recent Technologies and Patents on Silica Nanoparticles for Cancer Treatment and Diagnosis.
Gupta A; Kushwaha SS; Mishra A
Recent Pat Drug Deliv Formul; 2020; 14(2):126-144. PubMed ID: 32928094
[TBL] [Abstract][Full Text] [Related]
9. Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery.
Tang F; Li L; Chen D
Adv Mater; 2012 Mar; 24(12):1504-34. PubMed ID: 22378538
[TBL] [Abstract][Full Text] [Related]
10. Mesoporous silica nanoparticles for therapeutic/diagnostic applications.
Jafari S; Derakhshankhah H; Alaei L; Fattahi A; Varnamkhasti BS; Saboury AA
Biomed Pharmacother; 2019 Jan; 109():1100-1111. PubMed ID: 30551360
[TBL] [Abstract][Full Text] [Related]
11. Multifunctional mesoporous silica nanoparticles for combined therapeutic, diagnostic and targeted action in cancer treatment.
Rosenholm JM; Sahlgren C; Lindén M
Curr Drug Targets; 2011 Jul; 12(8):1166-86. PubMed ID: 21443474
[TBL] [Abstract][Full Text] [Related]
12. Mesoporous Silica Nanoparticles in Cancer Therapy: Relevance of the Targeting Function.
Pasqua L; Leggio A; Sisci D; Andò S; Morelli C
Mini Rev Med Chem; 2016; 16(9):743-53. PubMed ID: 26996622
[TBL] [Abstract][Full Text] [Related]
13. Drug delivery/imaging multifunctionality of mesoporous silica-based composite nanostructures.
Chen Y; Chen H; Shi J
Expert Opin Drug Deliv; 2014 Jun; 11(6):917-30. PubMed ID: 24746014
[TBL] [Abstract][Full Text] [Related]
14. New insights towards mesoporous silica nanoparticles as a technological platform for chemotherapeutic drugs delivery.
Sábio RM; Meneguin AB; Ribeiro TC; Silva RR; Chorilli M
Int J Pharm; 2019 Jun; 564():379-409. PubMed ID: 31028801
[TBL] [Abstract][Full Text] [Related]
15. Biocompatibility, biodistribution, and drug-delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animals.
Lu J; Liong M; Li Z; Zink JI; Tamanoi F
Small; 2010 Aug; 6(16):1794-805. PubMed ID: 20623530
[TBL] [Abstract][Full Text] [Related]
16. Protein-gold clusters-capped mesoporous silica nanoparticles for high drug loading, autonomous gemcitabine/doxorubicin co-delivery, and in-vivo tumor imaging.
Croissant JG; Zhang D; Alsaiari S; Lu J; Deng L; Tamanoi F; AlMalik AM; Zink JI; Khashab NM
J Control Release; 2016 May; 229():183-191. PubMed ID: 27016140
[TBL] [Abstract][Full Text] [Related]
17. Mesoporous silica nanoparticles for intracellular controlled drug delivery.
Vivero-Escoto JL; Slowing II; Trewyn BG; Lin VS
Small; 2010 Sep; 6(18):1952-67. PubMed ID: 20690133
[TBL] [Abstract][Full Text] [Related]
18. Cancer-targeted and intracellular delivery of Bcl-2-converting peptide with functional macroporous silica nanoparticles for biosafe treatment.
Wu Y; Ge P; Xu W; Li M; Kang Q; Zhang X; Xie J
Mater Sci Eng C Mater Biol Appl; 2020 Mar; 108():110386. PubMed ID: 31923940
[TBL] [Abstract][Full Text] [Related]
19. Mesoporous Silica Nanoparticles as a Prospective and Promising Approach for Drug Delivery and Biomedical Applications.
Pu X; Li J; Qiao P; Li M; Wang H; Zong L; Yuan Q; Duan S
Curr Cancer Drug Targets; 2019; 19(4):285-295. PubMed ID: 30520373
[TBL] [Abstract][Full Text] [Related]
20. Mesoporous silica nanoparticles: synthesis, classification, drug loading, pharmacokinetics, biocompatibility, and application in drug delivery.
Li Z; Zhang Y; Feng N
Expert Opin Drug Deliv; 2019 Mar; 16(3):219-237. PubMed ID: 30686075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
